Target intelligence / Profile preview

CUGBP Elav-like family member 4 (CELF4)

Target
CELF4
Molecular classification
RNA-binding protein, post-transcriptional regulator, splicing factor, other
01

Overview

CUGBP Elav-like family member 4 (CELF4) is a neuron-enriched RNA-binding protein that plays a vital role in the post-transcriptional regulation of gene expression, especially in the central nervous system[1][3][6]. It is characterized by multiple RNA recognition motifs (RRMs) that enable it to regulate alternative splicing, mRNA stability, and translation[1][7]. CELF4 expression is primarily found in excitatory neurons in the brain, where it controls the abundance and localization of mRNAs important for synaptic development and function[2][3][6]. Disruption or deficiency of CELF4 is linked to neurological disorders such as epilepsy and autism spectrum disorder, as mouse models show increased cortical excitability and seizures upon CELF4 loss[2][7]. Recent research has also implicated CELF4 in pathological cardiac remodeling, especially fibrosis and heart failure, positioning it as an emerging therapeutic target in both neurological and cardiovascular disease[4]. No known drugs directly target CELF4, and its role as a clinical biomarker or safety considerations are still under investigation.

Other names
bruno-like protein 4BRUNOL4CUGBP- and ETR-3-like factor 4RNA-binding protein BRUNOL-4LYST-interacting protein LIP9bruno-like 4CELF-4CELF4
02

Biological functions

regulation of pre-mRNA alternative splicingregulation of mRNA stabilityregulation of mRNA translationneuronal RNA granule assemblysynaptic plasticityregulation of excitatory neurotransmissionregulation of cardiac remodeling
03

Disease associations

epilepsyautism spectrum disorderneurodevelopmental disordercardiac fibrosisheart failure
04

Safety considerations

potential for increased seizure risk due to altered neuronal excitabilitypossible impact on cardiac remodeling and fibrosis

Beyond the preview

Go deeper on CUGBP Elav-like family member 4 (CELF4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CUGBP Elav-like family member 4 (CELF4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call